CUBIST PHARMACEUTICALS INC - NOTE 1.875% 9/0

CUSIP: 229678AH0

Q4 2014 13F Holders as of 31 Dec 2014

Type / Class
Debt / NOTE 1.875% 9/0
Market price (% of par)
136.07%
Total 13F principal
$353,812,053
Principal change
-$45,780,534
Total reported market value
$496,560,000
Number of holders
34
Value change
-$16,093,157
Number of buys
20
Number of sells
22

Quarterly Holders Quick Answers

What is CUSIP 229678AH0?
CUSIP 229678AH0 identifies 229678AH0 - CUBIST PHARMACEUTICALS INC - NOTE 1.875% 9/0 in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of CUBIST PHARMACEUTICALS INC - NOTE 1.875% 9/0 as of Q4 2014

As of 31 Dec 2014, CUBIST PHARMACEUTICALS INC - NOTE 1.875% 9/0 was held by 34 institutional bondholders reporting positions in Form 13F filings. These institutions reported holding $353,812,053 in principal (par value) of the bond. The largest 10 bondholders included FMR LLC, ROYAL BANK OF CANADA, Magnetar Financial LLC, Polar Securities Inc., Calamos Advisors LLC, UBS OCONNOR LLC, GLAZER CAPITAL, LLC, CSS LLC/IL, PIONEER INVESTMENT MANAGEMENT INC, and CAPSTONE INVESTMENT ADVISORS, LLC. This page lists 34 institutional bondholders reporting positions for the Q4 2014 filing period.
Investor Option Weight % Change % Value $ * Price (% of par) Principal Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.